Sep 22, 2026 10 0
Uploaded by Theodore
Favorite
Share
More Options
17
The PARP1 selective inhibitor saruparib (AZD5305) elicits potent and durable antitumor activity in patient-derived BRCA1/2-associated cancer models_Page 1

Open in WPS to view all 17 pages